Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Angelina M. M. Basso"'
Autor:
Maria Eugênia Lisei-de-Sa, Nelson Geraldo de Oliveira, Angelina M. M. Basso, Magda Aparecida Beneventi, Fabricio B. M. Arraes, Junya Mizoi, Isabela Tristan Lourenço-Tessutti, Regina M. S. Amorim, Muhammad Faheem, Giovani Greigh de Brito, Maria Cristina Mattar da Silva, Maria Fatima Grossi-de-Sa, Kazuko Yamaguchi-Shinozaki
Publikováno v:
Agricultural Sciences. :1195-1225
Drought is a major environmental factor limiting cotton (Gossypium hirsutum L.) productivity worldwide and projected climate changes could increase their negative effects in the future. Thus, targeting the molecular mechanisms correlated with drought
Autor:
Angelina M. M. Basso, E R Carbonero, Maria Fatima Grossi-de-Sa, V L P Polez, R. de Castro, Vitor H. Pomin, Anamélia Lorenzetti Bocca, H I Guimarães, T B de Castro, Aldo Henrique Tavares, Christian Hoffmann
Publikováno v:
Medical mycology. 58(2)
Current antifungal drugs present poor effectiveness and there is no available vaccine for fungal infections. Thus, novel strategies to treat or prevent invasive mycosis, such as cryptococcosis, are highly desirable. One strategy is the use of immunom
Autor:
Kelly Grace Magalhães, Pedro Henrique Bürgel, Anamélia Lorenzetti Bocca, Isaque Medeiros Siqueira, Aldo Henrique Tavares, Stephan Alberto Machado de Oliveira, Angelina M. M. Basso, Raffael Júnio Araújo de Castro, Luiza Chaves de Miranda Leonhardt, Márcio Sousa Jerônimo, Paulo Henrique de Holanda Veloso Júnior
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Fonsecaea pedrosoi is the main etiologic agent of chromoblastomycosis (CBM), one of the most prevalent subcutaneous mycosis in tropical and subtropical countries. CBM is a poorly characterized chronic infection that commonly starts after transcutaneo
Since the development of the first biopharmaceutical, more than 200 approved drugs have entered the market that were developed through different biotechnological routes and licensed for several therapeutic goals. These biomolecules are divided into s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b5c628eff1fe7a66c62fc6cb5216740
https://doi.org/10.1016/b978-0-444-63660-7.00002-4
https://doi.org/10.1016/b978-0-444-63660-7.00002-4
Autor:
Rayssa Almeida Garcia, Maria Fatima Grossi-de-Sa, Danila Cabral do Nascimento, Leonardo Lima Pepino de Macedo, Angelina M. M. Basso, Muhammad Faheem, Clidia Eduarda Moreira-Pinto, François-Xavier Gillet, Maria Cristina Mattar da Silva
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0189600 (2017)
PLoS ONE
PLoS ONE
RNA interference (RNAi) approaches have been applied as a biotechnological tool for controlling plant insect pests via selective gene down regulation. However, the inefficiency of RNAi mechanism in insects is associated with several barriers, includi
Autor:
Luciano P. Silva, Antônio Américo Barbosa Viana, Angelina M. M. Basso, Fernanda Mulinari, Patrícia B. Pelegrini, Maria Fatima Grossi-de-Sa, Michelle C Costa
Publikováno v:
AMB Express
In Brazil, there is a growing demand for specialised pharmaceuticals, and the high cost of their importation results in increasing costs, reaching US$ 1.34 billion in 2012 and US$ 1.61 billion in 2013. Worldwide expenses related to drugs could reach
Publikováno v:
Journal of Bioequivalence & Bioavailability.
According to the World Health Organization (WHO), one third of the world’s population don’t have the necessary access to pharmaceutical products, including essential drugs. In Brazil, the Governmental Health System (SUS) distributes some medicame